Gene · 5518
Papers1,733
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,733
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ECPPF stratification identifies occult high-risk subgroups in stage I, grade 1 or 2, ≤50 % invasive endometrial cancer: Candidates for adjuvant therapy. | Gynecol Oncol | 2025 | 40199195 | PubTator, text mining | PubMed |
| A chemical-genetic system to rapidly inhibit the PP2A-B56 phosphatase reveals a role at metaphase kinetochores. | Nat Commun | 2025 | 40157924 | PubTator, text mining | PubMed |
| A de novo missense variant Ser219Pro in PPP2R1A leads to macrocephaly in Houge-Janssens syndrome type 2. | Clin Dysmorphol | 2025 | 40073204 | PubTator, text mining | PubMed |
| Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum. | Am J Hum Genet | 2025 | 39978342 | PubTator, text mining | PubMed |
| Epigenetic Signatures and Prognostic Biomarkers Analysis of Methylation-Driven Genes in Uterine Endometrial Carcinosarcoma. | Crit Rev Eukaryot Gene Expr | 2025 | 39957591 | PubTator, text mining | PubMed |
| PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma. | Oncogene | 2025 | 39939726 | PubTator, text mining | PubMed |
| The anti-neuroinflammatory effects of cepharanthine in uric acid-induced neuroinflammation. | J Ethnopharmacol | 2025 | 39870338 | PubTator, text mining | PubMed |
| Effect of Propolis on PPP2R1A and Apoptosis in Cancer Cells. | Biochem Res Int | 2025 | 39850502 | PubTator, text mining | PubMed |
| IMPDH2 dephosphorylation under FGFR signaling promotes S-phase progression and tumor growth. | Cell Rep | 2025 | 39739531 | PubTator, text mining | PubMed |
| Endometrial carcinomas with ambiguous histology often harbor TP53 mutations. | Virchows Arch | 2025 | 39235515 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Computational investigations into structure and function impact of novel mutations identified in targeted exons from ovarian cancer cell lines. | J Biomol Struct Dyn | 2025 | 38334284 | PubTator, text mining | PubMed |
| Novel kinase regulators of extracellular matrix internalisation identified by high-content screening modulate invasive carcinoma cell migration. | PLoS Biol | 2024 | 39666682 | PubTator, text mining | PubMed |
| Exosomal mRNA Signatures as Predictive Biomarkers for Risk and Age of Onset in Alzheimer's Disease. | Int J Mol Sci | 2024 | 39596356 | PubTator, text mining | PubMed |
| PCYT2 inhibits epithelial-mesenchymal transition in colorectal cancer by elevating YAP1 phosphorylation. | JCI Insight | 2024 | 39531326 | PubTator, text mining | PubMed |
| Targeting Protein Kinase, Membrane-Associated Tyrosine/Threonine 1 (PKMYT1) for Precision Cancer Therapy: From Discovery to Clinical Trial. | J Med Chem | 2024 | 39383322 | PubTator, text mining | PubMed |
| BRG1 promotes progression of B-cell acute lymphoblastic leukemia by disrupting PPP2R1A transcription. | Cell Death Dis | 2024 | 39187513 | PubTator, text mining | PubMed |
| Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses. | Sci Rep | 2024 | 39169044 | PubTator, text mining | PubMed |
| Prenatal Diagnosed Agenesis of the Corpus Callosum: Identifying the Underlying Genetic Etiologies. | Prenat Diagn | 2024 | 39117575 | PubTator, text mining | PubMed |
| African swine fever virus structural protein p17 inhibits IRF3 activation by recruiting host protein PR65A and inducing apoptotic degradation of STING. | Front Microbiol | 2024 | 38957619 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5518/papers?page=3